Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 25 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-07 4 AS $87.58 $262,740 D/D (3,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-08 4 AS $91.14 $549,523 D/D (6,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-08 4 OE $14.39 $86,340 D/D 6,000 294,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-10 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-10 4 AS $90.55 $271,650 D/D (3,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 AS $93.79 $375,160 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-22 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-22 4 AS $96.82 $290,460 D/D (3,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-05 4 AS $98.63 $394,520 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-05 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-14 4 AS $95.20 $380,800 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-14 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-21 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-21 4 AS $90.12 $270,360 D/D (3,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-27 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-27 4 AS $91.78 $367,120 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-01 4 A $0.00 $0 D/D 45,320 333,610 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-01 4 D $94.76 $465,177 D/D (4,909) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-07 4 AS $90.78 $363,120 D/D (4,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-07 4 OE $14.39 $57,560 D/D 4,000 332,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-11 4 OE $14.39 $71,950 D/D 5,000 333,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-11 4 AS $88.96 $444,780 D/D (5,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-12 4 AS $91.44 $365,770 D/D (4,000) 328,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-12 4 OE $14.39 $57,560 D/D 4,000 332,701 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25  26   27   28   29   30   31   32   33   34      
  Page 25 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us